Asian Fund for Cancer Research Limited – AFCR shared on LinkedIn:
“Convener, connector, and catalyst.
That’s how our Founder and CEO, Dr. Sujuan Ba, describes AFCR’s role in a new Asia Bio Inc profile.
Title: Sujuan Ba: building bridges for Asian cancer research
Author: Donglei Mao
The article traces how Asian Fund for Cancer Research Limited grew from a simple observation: Western and Chinese scientists wanted to collaborate, but no platform connected them. It also looks at how linking discovery, translation, capital, and patients can help Hong Kong become a leading biotech hub.
As Dr. Ba says, the goal is to make sure the benefits of cancer research reach patients wherever they live.
Thank you to Asia Bio Inc and Donglei Mao for telling this story.”
You can also read:
Empowering Underserved Cancer Communities in Asia Through the Patient Community Hub – AFCR
